About this Journal Submit a Manuscript Table of Contents
Cardiology Research and Practice
Volume 2012 (2012), Article ID 407035, 6 pages
http://dx.doi.org/10.1155/2012/407035
Review Article

Extravascular Lung Water and Acute Lung Injury

Division of Intensive Care Medicine, King's College Hospital, Denmark Hill, London SE5 9RS, UK

Received 12 May 2011; Revised 12 June 2011; Accepted 28 June 2011

Academic Editor: Antoine Vieillard-Baron

Copyright © 2012 Ritesh Maharaj. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Acute lung injury carries a high burden of morbidity and mortality and is characterised by nonhydrostatic pulmonary oedema. The aim of this paper is to highlight the role of accurate quantification of extravascular lung water in diagnosis, management, and prognosis in “acute lung injury” and “acute respiratory distress syndrome”. Several studies have verified the accuracy of both the single and the double transpulmonary thermal indicator techniques. Both experimental and clinical studies were searched in PUBMED using the term “extravascular lung water” and “acute lung injury”. Extravascular lung water measurement offers information not otherwise available by other methods such as chest radiography, arterial blood gas, and chest auscultation at the bedside. Recent data have highlighted the role of extravascular lung water in response to treatment to guide fluid therapy and ventilator strategies. The quantification of extravascular lung water may predict mortality and multiorgan dysfunction. The limitations of the dilution method are also discussed.

1. Introduction

In 1896, the physiologist Starling described the factors that influence fluid transport across semipermeable membranes like capillaries [1]. This description accounted for the net movement of fluids between compartments in relation to capillary and interstitial hydrostatic pressures, capillary and interstitial oncotic pressures, and coefficients of capillary permeability. Pulmonary oedema refers to the accumulation of fluid within the extravascular space of the lung and occurs when the Starling forces are unbalanced. This occurs most commonly from an increased pulmonary capillary hydrostatic pressure or an increased capillary permeability. The estimation of the severity of pulmonary oedema by chest auscultation, radiography, or arterial blood gas analysis is imprecise [24]. Chest auscultation may be altered by mechanical ventilation, and bedside chest radiographs in the critical care unit is subject to several technical limitations. There is poor correlation between the chest radiograph scores of pulmonary oedema and the actual amount of EVLW [5]. There is also high interobserver variability when applying the American-European Consensus Conference radiographic criteria for ARDS even amongst experts [6, 7]. Data from experimental studies suggest that EVLW on chest radiography may only be detectable when the lung water increases by more than 35% [8]. Experimental studies have also shown that arterial oxygenation decreased significantly only when the EVLW increases by more than 200% [4]. Hypoxaemia may be due to causes other than pulmonary oedema, and it is estimated that up to one-third of patients with ALI do not have any significant pulmonary oedema [911]. The ability to accurately measure EVLW within increments from 10 to 20% offers the potential to identify those patents that may benefit from fluid restriction, dieresis, or other therapies. The aims of this study are to critically analyze clinical studies investigating the prognostic and therapeutic values of EVLW measurement.

2. Materials and Methods

Studies were searched in PUBMED by using the terms “extravascular lung water” (EVLW) and “acute lung injury” (ALI) or “acute respiratory distress syndrome” (ARDS) as keywords. The search was further refined by selecting studies investigating the use of dilution methods to assess EVLW in ARDS or ALI. The authors used backward snowballing (i.e., scanning of references of retrieved articles and reviews).

3. Results and Discussion

The measurement of EVLW has been under investigation for about 40 years with the first report of the use of EVLW in the clinical management of critically ill patients by Eisenberg and colleagues more than 20 years ago [12]. The bedside method used to measure EVLW was the double-indicator technique. This method requires the simultaneous injection of an intravascular dye indicator and a diffusible (cold saline) indicator. It is assumed that the dye will remain in the intravascular space and the cold temperature will be distributed throughout the thoracic cavity. Differences in the dilution curves allow the calculation of EVLW. The difference in the mean transit time (MTt) multiplied by the cardiac output determine the extravascular thermal distribution volume, that is, intrathoracic thermal volume (ITTV) via cold saline − intrathoracic blood volume (ITBV) via dye dilution = EVLW. This technique is cumbersome, time consuming, and has not been widely used.

The single-indicator method uses a thermal indicator to calculate EVLW. Cold saline is injected through a central venous catheter, and the thermistor tip on a femoral arterial catheter, measures the downstream change in temperature in the abdominal aorta. The investigators Sakka et al. were able to quantify the relationship between the ITBV and the global end diastolic volume (GEDV), that is, that total volume and the end of diastole within all four chambers of the heart [13]. The equation is  mL. Other investigators have confirmed a similar relationship between ITBV and GEDV [14, 15]. The derivation of EVLW using a single-indicator technique is described in Figure 1 and a more detailed description is available elsewhere [15]. The EVLW represents both interstitial and alveolar fluid. The intrathoracic thermal volume (ITTV) is the product of cardiac output and the MTt. The pulmonary thermal volume is the product of the cardiac output and the exponential downslope time. The difference between the ITTV and the ITBV is an estimate of the EVLW. The accuracy of this technique compares favorably with the gravimetric method, the gold standard test for EVLW [16, 17]. Various formulas relating ITBV to GEDV are reported in Table 1. Importantly, there are no significant differences between the values for ITBV derived from these formulas [18].

tab1
Table 1: Different formulas for the calculations of ITBV reported in the current literature.
407035.fig.001
Figure 1: Thermodilution curves showing mean transit time (MTt) and downslope decay time (DSt) of the slope. The time point (A) represents the time of injection. The product of cardiac output and MTt equals the intrathoracic thermal volume. Multiplication of the cardiac output and the DSt equals the pulmonary thermal volume (PTV). The global end diastolic volume (GEDV) is equal to the ITTV − PTV. The intrathoracic blood volume = . The extravascular lung water (EVLW) is equal to the ITTV less the ITBV.

4. Distinguishing between Cardiogenic and Permeability Pulmonary Oedema

Evidence from several small studies suggests that the ratio of EVLW to ITBV may provide some clue to the cause of pulmonary oedema [1921]. Early studies used the ratio of the EVLW and the volume of blood within the lungs, that is, the pulmonary blood volume to derive the pulmonary vascular permeability index [2224]. More recently investigators have attempted to establish the diagnostic value of the EVLW/ITBV ratio [20, 25]. A high EVLW/ITBV ratio would support an increased permeability as the cause, whereas a low ratio would suggest hydrostatic pulmonary oedema. A small study of twenty mechanically ventilated patients by van der Heijden and Groeneveld explored the relationship between pulmonary leak index (PLI) for gallium labeled transferrin and EVLW/ITBV ratios before and after fluid loading in nonseptic patients [26]. The PLI refers to the transvascular transport rate of a protein bound radionuclide, such as 67Ga-transferrin or 99mtechnetium-albumin, measured by a bedside probe. A threshold EVLW/ITBV ratio of 0.23 had a positive predictive value of 39% and a negative predictive value of 82% for a high PLI. A similar study in sepsis-related ARDS/ALI found a statistically significant but weak relationship between EVLW and ITBV (P = 0.045, = 0.43) [27]. These findings are unsurprising as the sensitivity and specificity of PLI in distinguishing cardiogenic and permeability pulmonary oedema is itself poor. The ITBV may be rapidly reduced when positive pressure ventilation is initiated limiting the interpretation of this ratio. These studies support earlier reports that highlight the potential value and some of the limitations of using EVLW/ITBV ration in trying to distinguish between hydrostatic and permeability pulmonary oedema. The EVLW/ITBV ratio remains an interesting physiologic concept and warrants further clinical enquiry.

5. Informing Fluid Therapy

Septic shock and ALI often coexist and require directed interventions. Fluid therapy is an intervention widely applied to almost all critically ill patients and there is consensus that volume resuscitation should occur promptly [28, 29]. Concerns about restoring tissue perfusion must be balanced against the potential harms of volume excess. Simply, being volume responsive does not imply an improved outcome to the administration of volume, and there is some concern about the liberal use of fluids in critically ill patients [30]. A large randomized trial by the ARDS Clinical Trials Network compared liberal and conservative fluid strategies in patients with ALI/ARDS [31]. The 72-hour cumulative for the conservative group was 400 mL and 5100 mL in the liberal group. The study found no difference in mortality at 60 days (25.5% in the restrictive group versus 28.4 for the liberal group, P = 0.3). Patients in the conservative group showed an increase in ventilator-free days, reduced ICU stay, no increase in nonpulmonary organ failure, and a trend towards a reduced need for renal replacement therapy. A positive fluid balance in patients with ALI is associated with higher mortality in patients with ALI/ARDS [32]. While these studies did not measure EVLW, it may provide a rational way to monitor patients with ALI/ARDS. Indeed, more than 20 years ago, Eisenberg et al. compared protocol- (EVLW-) guided therapy to routine (pulmonary artery wedge pressure-guided) haemodynamic management in 48 critically ill patients [12]. The study reported a shorter time on mechanical ventilation as well as a lower mortality. The study also showed that restrictive fluid strategies could be safe and well tolerated in patients with ARDS. A follow-up study by Mitchell and colleagues enrolled 101 patients that to the EVLW- and wedge pressure-guided strategies [33]. The EVLW group had a lower positive fluid balance as well as less ventilator days and a shorter ICU stay.

EVLW has also been used to guide fluid therapy in a cohort of patients with subarachnoid haemorrhage and has been shown to be safe and reduced pulmonary complications [34].

ARDS is frequently associated with right heart dysfunction. It is estimated that up to 25% of patients with ARDS may develop acute cor pulmonale (ACP), the most severe form of right ventricular dysfunction [35]. In these patients, fluid administration may exacerbate right ventricular dilatation, worsening ACP. EVLW-guided therapy may offer a method to safely balance resuscitation against the potential harms of fluid excess.

6. Titrating PEEP

The consensus view about mechanical ventilation in patients with ALI is to use the appropriate level of PEEP to recruit collapsed lung while delivering small tidal volumes [36]. This simple intervention may have harmful effects on haemodynamic function and gas exchange, and the optimal PEEP has been the subject of substantial investigation [37]. Many techniques have been suggested to titrate the appropriate level of PEEP. These include increasing PEEP to achieve the maximum oxygenation, trading improvements in oxygen delivery against improvements in oxygenation, using pressure volume curves or dynamic stress indices or imaging techniques such as chest radiography and computed tomography [38]. The lack of effect of any of these techniques in large cohorts of patients may reflect the need for a more patient-centered approach. The application of PEEP may affect the measurement of EVLW by dilution methods as well as the actual amount of EVLW [39]. Increasing PEEP may reduce pulmonary vascular flow reducing the measured EVLW [39]. Increasing PEEP may also increase pulmonary flow to previously excluded areas, increasing the measured EVLW [40, 41]. Increasing PEEP may increase the actual EVLW by increasing central venous pressure, creating backward pressure on lymph flow [42]. A decreased pulmonary interstitial pressure may have a similar effect. Increasing PEEP may decrease actual EVLW by decreasing cardiac output, decreasing pulmonary capillary pressure. The application of PEEP may improve oxygenation without significantly changing EVLW. The mechanism in this situation is likely to be recruitment of atelectatic lung. The relationship between PEEP and EVLW remains unsettled and titrating PEEP to individual patients requires consideration of several variables. Comparing pre- and postintervention oxygenation, EVLW and EVLW/ITBV ratios may offer insight into whether the patient has recruited atelectatic lung, haemodynamic changes, pulmonary capillary permeability, and/or hydrostatic forces. This may help to individualize PEEP titration at the bedside.

7. Predicting Outcome

Prognostication is an important part of communicating with surrogates and in making decisions about treatment. Despite a wealth of knowledge about ALI and ARDS, prognostication remains difficult [43]. There is considerable overlap between the predictors of mortality in patients with ALI and the predictors of death in the general ICU patient [43]. Age, haematocrit, bilirubin, and 24-hour fluid balance have all been shown to useful clinical predictors from the ARDSNet study [43, 44]. More recently increased EVLW has been identified as a strong predictor or mortality in ALI. Sakka et al. performed retrospective analysis of 373 patients and showed that EVLW was higher in nonsurvivors compared with survivors (median: 14.3 mL/kg versus 10.2 mL/kg, resp., P < 0.0001) and predicted mortality independent of SAPS II or APACHE II score by regression modeling [45]. The study also identified a dose effect with mortality lowest in the group with EVLW < 7 mL/kg (<30%), intermediate in the groups <7–14 mL/kg (40%) and 15–20 mL/kg (60%), and highest in the group with EVLW > 20 mL/kg (80% mortality). A threshold of 15 mL/kg was able to discriminate survivors from nonsurvivors (P = 0.002). A small prospective study by Kuzkov and colleagues showed a significant correlation between increased EVLW and recognized markers of severity in ALI such as ling compliance, oxygenation ratio, and lung injury score [46]. A significant proportion of patients with ARDS are overweight and EVLW indexed to predicted body weight (PBW) compared with actual body weight (ABW) is higher (20.6 ± 4.6 versus 11.6 ± 1.9 mL/kg; P = 0.002) [47]. A 3-day mean EVLW > 16 mL/kg indexed to PBW was found to predict death with 100% sensitivity and 86% specificity. A recent observational cohort study by Craig et al. showed that an elevated EVLW indexed to PBW measured within 48 hours of admission to ICU was significantly associated with mortality [48]. The median EVLW was 17.5 mL/kg (IQR 15.3–21.4) for non-ICU survivors and 10.6 mL/kg (IQR 9.5–15.4) for ICU survivors; P <  0.0029. The a odds ratio for death of EVLW indexed to PBW was 4.3 (confidence interval 1.5–2.9) per standard deviation increase, independent of oxygenation index, and APACHE II or SAPS II score. The argument has been that lung volumes are more closely correlated with height and gender than with actual body weight. Therefore, indexing EVLW to obese patients is likely to underestimate the severity of pulmonary oedema. An elevated EVLW indexed to PBW also predicts the development of multiorgan dysfunction syndrome (MODS) [49]. Data from small studies support the role of EVLW in predicting the clinical behavior during mechanical ventilation. High-frequency ventilation is better tolerated in patients with an EVLW > 15 mL/kg and pressure support better tolerated when the EVLW < 11 mL/kg [50, 51]. While the signal from these small, single center studies is encouraging, there is a lack of consensus about the definition of the normal values for EVLW or whether EWLV should be indexed to PBW or ABW.

8. Limitations of EVLW

It is estimated that up to one-third of patients with ALI/ARDS criteria do not have significant pulmonary oedema [9, 52, 53]. The mechanism for hypoxaemia in this group of patients may be due to atelectasis or consolidation in these patients. The diagnosis of ALI/ARDS on clinical criteria does not correlate well with autopsy findings [54]. EVLW may offer a reliable means of characterising ALI/ARDS by identifying those patients with increased pulmonary vascular permeability. This offers the prospect of a more homogenous group of patients that may benefit from interventions such as fluid restriction and diuresis and to recruit for further clinical trials. The measurement of EVLW may be altered by systematic or accidental errors of measurement. The single-indicator method relies on a predictable and constant relationship between the GEDV and the ITBV. Underperfusion that occurs pulmonary resection, pulmonary embolism, and pulmonary arterial occlusion may underestimate EVLW by about 10% [55, 56]. Experimental evidence suggests that this observation occurs only when vessels with a diameter >500 μm are occluded [57]. High cardiac output states may not allow sufficient time for equilibration with the extravascular distribution volume. Michard et al. studied the effect of cardiac index changes in critically ill patients in the range 1.9 L/min/m2 to 7.1 L/min/m2 as well as hyper- an hypovolaemic states but found no change in the relationship between GEDV and ITBV [15]. The presence of an intra-aortic balloon pump (IABP) renders continuous pulse contour analysis inaccurate but does not affect the accurate estimation of EVLW [58]. The same applies for the concomitant use of renal replacement therapy. EVLW calculation is accurate, provided that the vascular access catheter is not in the path of the indicator. A large aortic aneurysm may lead to underestimation of the EVLW and intracardiac shunts have unpredictable effects on the measured EVLW [59].

9. Conclusion

The use of thermodilution techniques to assess EVLW provides an accurate and readily accessible method at the bedside in critically ill patients. EVLW may have value in decision making about titrating PEEP, predicting clinical behavior during mechanical ventilation, guiding fluid therapy, and manipulating fluid balance and ultimately about prognostication.

References

  1. E. H. Starling, “On the absorption of fluids from the connective tissue spaces,” The Journal of Physiology, vol. 19, no. 4, pp. 312–326, 1896.
  2. D. Lichtenstein, I. Goldstein, E. Mourgeon, P. Cluzel, P. Grenier, and J. J. Rouby, “Comparative diagnostic performances of auscultation, chest radiography, and lung ultrasonography in acute respiratory distress syndrome,” Anesthesiology, vol. 100, no. 1, pp. 9–15, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. E. D. Sivak, B. J. Richmond, P. B. O'Donovan, and G. P. Borkowski, “Value of extravascular lung water measurement vs portable chest X-ray in the management of pulmonary edema,” Critical Care Medicine, vol. 11, no. 7, pp. 498–501, 1983. View at Scopus
  4. P. Scillia, M. Delcroix, P. Lejeune et al., “Hydrostatic pulmonary edema: evaluation with thin-section CT in dogs,” Radiology, vol. 211, no. 1, pp. 161–168, 1999. View at Scopus
  5. E. D. Sivak, B. J. Richmond, P. B. O'Donovan, and G. P. Borkowski, “Value of extravascular lung water measurement vs portable chest X-ray in the management of pulmonary edema,” Critical Care Medicine, vol. 11, no. 7, pp. 498–501, 1983. View at Scopus
  6. M. O. Meade, R. J. Cook, G. H. Guyatt et al., “Interobserver variation in interpreting chest radiographs for the diagnosis of acute respiratory distress syndrome,” American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 1, pp. 85–90, 2000. View at Scopus
  7. G. D. Rubenfeld, E. Caldwell, J. Granton, L. D. Hudson, and M. A. Matthay, “Interobserver variability in applying a radiographic definition for ARDS,” Chest, vol. 116, no. 5, pp. 1347–1353, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. P. D. Snashall, S. J. Keyes, B. M. Morgan, et al., “The radiographic detection of acute pulmonary oedema. A comparison of radiographic appearances, densitometry and lung water in dogs,” The British Journal of Radiology, vol. 54, no. 640, pp. 277–280, 1981.
  9. F. Michard, V. Zarka, S. Alaya, S. Sakka, and M. Klein, “Better characterization of acute lung injury/ARDS using lung water,” Chest, vol. 125, no. 3, pp. 1166–1167, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. G. S. Martin, S. Eaton, M. Mealer, and M. Moss, “Extravascular lung water in patients with severe sepsis: a prospective cohort study,” Critical Care, vol. 9, no. 2, pp. R74–82, 2005. View at Scopus
  11. A. B. J. Groeneveld and K. H. Polderman, “Acute lung injury, overhydration or both?” Critical Care, vol. 9, no. 2, pp. 136–137, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. P. R. Eisenberg, J. R. Hansbrough, D. Anderson, and D. P. Schuster, “A prospective study of lung water measurements during patient management in an intensive care unit,” American Review of Respiratory Disease, vol. 136, no. 3, pp. 662–668, 1987. View at Scopus
  13. S. G. Sakka, C. C. Rühl, U. J. Pfeiffer et al., “Assessment of cardiac preload and extravascular lung water by single transpulmonary thermodilution,” Intensive Care Medicine, vol. 26, no. 2, pp. 180–187, 2000. View at Scopus
  14. D. A. Reuter, T. W. Felbinger, K. Moerstedt et al., “Intrathoracic blood volume index measured by thermodilution for preload monitoring after cardiac surgery,” Journal of Cardiothoracic and Vascular Anesthesia, vol. 16, no. 2, pp. 191–195, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. F. Michard, A. Schachtrupp, and C. Toens, “Factors influencing the estimation of extravascular lung water by transpulmonary thermodilution in critically ill patients,” Critical Care Medicine, vol. 33, no. 6, pp. 1243–1247, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. J. C. Bock and F. R. Lewis, “Clinical relevance of lung water measurement with the thermal-dye dilution technique,” Journal of Surgical Research, vol. 48, no. 3, pp. 254–265, 1990. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Tagami, S. Kushimoto, Y. Yamamoto et al., “Validation of extravascular lung water measurement by single transpulmonary thermodilution: human autopsy study,” Critical Care, vol. 14, no. 5, p. R162, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. F. Michard, “Bedside assessment of extravascular lung water by dilution methods: temptations and pitfalls,” Critical Care Medicine, vol. 35, no. 4, pp. 1186–1192, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. X. Monnet, N. Anguel, D. Osman, O. Hamzaoui, C. Richard, and J. L. Teboul, “Assessing pulmonary permeability by transpulmonary thermodilution allows differentiation of hydrostatic pulmonary edema from ALI/ARDS,” Intensive Care Medicine, vol. 33, no. 3, pp. 448–453, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. A. B. J. Groeneveld and J. Verheij, “Extravascular lung water to blood volume ratios as measures of permeability in sepsis-induced ALI/ARDS,” Intensive Care Medicine, vol. 32, no. 9, pp. 1315–1321, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. J. Verheij, P. G. H. M. Raijmakers, A. Lingen, and A. B. J. Groeneveld, “Simple vs complex radionuclide methods of assessing capillary protein permeability for diagnosing acute respiratory distress syndrome,” Journal of Critical Care, vol. 20, no. 2, pp. 162–171, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. A. B. J. Groeneveld, P. G. H. M. Raijmakers, G. J. J. Teule, and L. G. Thijs, “The 67Gallium pulmonary leak index in assessing the severity and course of the adult respiratory distress syndrome,” Critical Care Medicine, vol. 24, no. 9, pp. 1467–1472, 1996. View at Scopus
  23. P. G. H. M. Raijmakers, A. B. J. Groeneveld, J. A. Rauwerda, G. J. J. Teule, and C. E. Hack, “Acute lung injury after aortic surgery: the relation between lung and leg microvascular permeability to 111indium-labelled transferrin and circulating mediators,” Thorax, vol. 52, no. 10, pp. 866–871, 1997. View at Scopus
  24. P. G. H. M. Raijmakers, A. B. J. Groeneveld, G. J. J. Teule, and L. G. Thijs, “Diagnostic value of the gallium-67 pulmonary leak index in pulmonary edema,” Journal of Nuclear Medicine, vol. 37, no. 8, pp. 1316–1322, 1996. View at Scopus
  25. A. B. J. Groeneveld, F. B. Plötz, and H. R. Van Genderingen, “Monitoring the permeability edema of ventilator-associated lung injury,” Critical Care Medicine, vol. 33, no. 1, pp. 250–252, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. M. van der Heijden and A. B. J. Groeneveld, “Extravascular lung water to blood volume ratios as measures of pulmonary capillary permeability in nonseptic critically ill patients,” Journal of Critical Care, vol. 25, no. 1, pp. 16–22, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. A. B. J. Groeneveld and J. Verheij, “Extravascular lung water to blood volume ratios as measures of permeability in sepsis-induced ALI/ARDS,” Intensive Care Medicine, vol. 32, no. 9, pp. 1315–1321, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. E. Rivers, B. Nguyen, S. Havstad et al., “Early goal-directed therapy in the treatment of severe sepsis and septic shock,” The New England Journal of Medicine, vol. 345, no. 19, pp. 1368–1377, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. S. M. Lin, C. D. Huang, H. C. Lin, C. Y. Liu, C. H. Wang, and H. P. Kuo, “A modified goal-directed protocol improves clinical outcomes in intensive care unit patients with septic shock: a randomized controlled trial,” Shock, vol. 26, no. 6, pp. 551–557, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. F. Michard and J. L. Teboul, “Predicting fluid responsiveness in ICU patients: a critical analysis of the evidence,” Chest, vol. 121, no. 6, pp. 2000–2008, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. H. P. Wiedemann, A. P. Wheeler, G. R. Bernard et al., “Comparison of two fluid-management strategies in acute lung injury,” The New England Journal of Medicine, vol. 354, no. 24, pp. 2564–2575, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. Y. Sakr, J. L. Vincent, and K. Reinhart, “High tidal volume and positive fluid balance are associated with worse outcome in acute lung injury,” Chest, vol. 128, no. 5, pp. 3098–3108, 2005.
  33. J. P. Mitchell, D. Schuller, F. S. Calandrino, and D. P. Schuster, “Improved outcome based on fluid management in critically ill patients requiring pulmonary artery catheterization,” American Review of Respiratory Disease, vol. 145, no. 5, pp. 990–998, 1992. View at Scopus
  34. T. Mutoh, K. Kazumata, M. Ajiki, S. Ushikoshi, and S. Terasaka, “Goal-directed fluid management by bedside transpulmonary hemodynamic monitoring after subarachnoid hemorrhage,” Stroke, vol. 38, no. 12, pp. 3218–3224, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. A. Vieillard-Baron, J. M. Schmitt, R. Augarde et al., “Acute cor pulmonale in acute respiratory distress syndrome submitted to protective ventilation: incidence, clinical implications, and prognosis,” Critical Care Medicine, vol. 29, no. 8, pp. 1551–1555, 2001. View at Scopus
  36. A. S. Slutsky, “Mechanical ventilation. American College of Chest Physicians' Consensus Conference,” Chest, vol. 104, no. 6, pp. 1853–1859, 1993.
  37. G. D. Rubenfeld, “How much PEEP in acute lung injury,” Journal of the American Medical Association, vol. 303, no. 9, pp. 883–884, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. L. Gattinoni, E. Carlesso, L. Brazzi, and P. Caironi, “Positive end-expiratory pressure,” Current Opinion in Critical Care, vol. 16, no. 1, pp. 39–44, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. J. C. Myers, T. E. Reilley, and C. T. Cloutier, “Effect of positive end-expiratory pressure on extravascular lung water in porcine acute respiratory failure,” Critical Care Medicine, vol. 16, no. 1, pp. 52–54, 1988. View at Scopus
  40. R. C. Allison, P. V. Carlile, and B. A. Gray, “Thermodilution measurement of lung water,” Clinics in Chest Medicine, vol. 6, no. 3, pp. 439–457, 1985. View at Scopus
  41. P. V. Carlile, D. D. Lowery, and B. A. Gray, “Effect of PEEP and type of injury on thermal-dye estimation of pulmonary edema,” Journal of Applied Physiology, vol. 60, no. 1, pp. 22–31, 1986. View at Scopus
  42. R. H. Demling, N. C. Staub, and L. H. Edmunds, “Effect of end expiratory airway pressure on accumulation of extravascular lung water,” Journal of Applied Physiology, vol. 38, no. 5, pp. 907–912, 1975. View at Scopus
  43. C. R. Cooke, J. M. Kahn, E. Caldwell et al., “Predictors of hospital mortality in a population-based cohort of patients with acute lung injury,” Critical Care Medicine, vol. 36, no. 5, pp. 1412–1420, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. C. R. Cooke, C. V. Shah, R. Gallop et al., “A simple clinical predictive index for objective estimates of mortality in acute lung injury,” Critical Care Medicine, vol. 37, no. 6, pp. 1913–1920, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. S. G. Sakka, M. Klein, K. Reinhart, and A. Meier-Hellmann, “Prognostic value of extravascular lung water in critically III patients,” Chest, vol. 122, no. 6, pp. 2080–2086, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. V. V. Kuzkov, M. Y. Kirov, M. A. Sovershaev et al., “Extravascular lung water determined with single transpulmonary thermodilution correlates with the severity of sepsis-induced acute lung injury,” Critical Care Medicine, vol. 34, no. 6, pp. 1647–1653, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. C. R. Phillips, M. S. Chesnutt, and S. M. Smith, “Extravascular lung water in sepsis-associated acute respiratory distress syndrome: indexing with predicted body weight improves correlation with severity of illness and survival,” Critical Care Medicine, vol. 36, no. 1, pp. 69–73, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. T. R. Craig, M. J. Duffy, M. Shyamsundar et al., “Extravascular lung water indexed to predicted body weight is a novel predictor of intensive care unit mortality in patients with acute lung injury,” Critical Care Medicine, vol. 38, no. 1, pp. 114–120, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. F. T. Chung, H. C. Lin, C. H. Kuo et al., “Extravascular lung water correlates multiorgan dysfunction syndrome and mortality in sepsis,” PLoS ONE, vol. 5, no. 12, article e15265, 2010. View at Publisher · View at Google Scholar · View at PubMed
  50. J. Zeravik, U. Borg, and U. J. Pfeiffer, “Efficacy of pressure support ventilation dependent on extravascular lung water,” Chest, vol. 97, no. 6, pp. 1412–1419, 1990. View at Scopus
  51. J. Zeravik and U. J. Pfeiffer, “Efficacy of high frequency ventilation combined with volume controlled ventilation in dependency of extravascular lung water,” Acta Anaesthesiologica Scandinavica, vol. 33, no. 7, pp. 568–574, 1989. View at Scopus
  52. A. B. J. Groeneveld and K. H. Polderman, “Acute lung injury, overhydration or both?” Critical Care, vol. 9, no. 2, pp. 136–137, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  53. G. S. Martin, S. Eaton, M. Mealer, and M. Moss, “Extravascular lung water in patients with severe sepsis: a prospective cohort study,” Critical Care, vol. 9, no. 2, pp. R74–82, 2005. View at Scopus
  54. A. Esteban, P. Fernández-Segoviano, F. Frutos-Vivar et al., “Comparison of clinical criteria for the acute respiratory distress syndrome with autopsy findings,” Annals of Internal Medicine, vol. 141, no. 6, 2004.
  55. O. Godje, M. Peyerl, T. Seebauer, O. Dewald, and B. Reichart, “Reproducibility of double indicator dilution measurements of intrathoracic blood volume compartments, extravascular lung water, and liver function,” Chest, vol. 113, no. 4, pp. 1070–1077, 1998. View at Scopus
  56. P. Rossi, M. Wanecek, A. Rudehill, D. Konrad, E. Weitzberg, and A. Oldner, “Comparison of a single indicator and gravimetric technique for estimation of extravascular lung water in endotoxemic pigs,” Critical Care Medicine, vol. 34, no. 5, pp. 1437–1443, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  57. L. Oppenheimer, V. B. Elings, and F. R. Lewis, “Thermal-dye lung water measurements: effects of edema and embolization,” Journal of Surgical Research, vol. 26, no. 5, pp. 504–512, 1979. View at Scopus
  58. M. Janda, T. W. L. Scheeren, J. Bajorat et al., “The Impact of intra-aortic balloon pumping on cardiac output determination by pulmonary arterial and transpulmonary thermodilution in pigs,” Journal of Cardiothoracic and Vascular Anesthesia, vol. 20, no. 3, pp. 320–324, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. S. G. Sakka, C. C. Rühl, U. J. Pfeiffer et al., “Assessment of cardiac preload and extravascular lung water by single transpulmonary thermodilution,” Intensive Care Medicine, vol. 26, no. 2, pp. 180–187, 2000. View at Scopus